Driehaus Capital Management LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 938206 Chicago, IL

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$89,612,476

+$13,626,665 QoQ

Shares Held

731,053

+1.4% QoQ

Ownership

1.13%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#23

of 341 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. PTGX ranks #15 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc.	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc.	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc.	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$89,612,476	731,053	+1.4%	Shares	Sole	2026-08-14
2026-03-31	$75,985,811	720,928	-34.4%	Shares	Sole	2026-05-15
2025-12-31	$96,001,507	1,099,170	-3.6%	Shares	Sole	2026-02-17
2025-09-30	$75,720,501	1,139,854	+50.4%	Shares	Sole	2025-11-14
2025-06-30	$41,878,631	757,710	+222.3%	Shares	Sole	2025-08-14
2025-03-31	$11,368,130	235,073	-30.8%	Shares	Sole	2025-05-15
2024-12-31	$13,112,342	339,698	-23.7%	Shares	Sole	2025-02-14
2024-09-30	$20,040,840	445,352	-20.0%	Shares	Sole	2024-11-14
2024-06-30	$19,294,332	556,835	-0.7%	Shares	Sole	2024-08-15
2024-03-31	$16,216,132	560,530	+182.1%	Shares	Sole	2024-05-15
2023-12-31	$4,555,938	198,689	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.